20th International Congress » Other

12:00pm-1:30pm

“Words untold”

P.M. Iyer, B. McGuiness, J. Scott, S. Manning, A. Chalisseri, D. Olszewska, M. Farrell, T. Lynch (Dublin, Ireland)

12:00pm-1:30pm

A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery

E.M. Feinstein, S.J. Frucht (New York, NY, USA)

12:00pm-1:30pm

A case with posttraumatic functional shoulder dyskinesia

S. Tezcan, M. Demirci, M.C. Akbostanci (Ankara, Turkey)

12:00pm-1:30pm

A community organizing approach to identify and address the barriers to healthcare for XDP patients in Panay Island, Philippines

G.M. Solinap, A.C. Aguil, P.B. Acuna, L.V. Lee, N. Sharma (Charlestown, MA, USA)

12:00pm-1:30pm

A comparison of standards of care in Parkinson’s disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines

S.M. Yap, M.O. Dablouk, S. O'Sullivan (Dublin, Ireland)

12:00pm-1:30pm

A cross-linguistic approach to speech intelligibility in people with PD

Y. Kim, Y. Choi (Baton Rouge, LA, USA)

12:00pm-1:30pm

A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)

12:00pm-1:30pm

A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test

E. Goz, F. Soke, A. Genc, B. Donmez Colakoglu, P. Keskinoglu (Izmir, Turkey)

12:00pm-1:30pm

A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)

12:00pm-1:30pm

Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)

12:00pm-1:30pm

Aquatic physical therapy: Functional motor skills in people with Parkinson’s disease

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)

12:00pm-1:30pm

Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases

F. Pullishery, F.M. Kuyyadi (Malappuram, India)

12:00pm-1:30pm

Association of amyotrophic lateral sclerosis with basal ganglia impairment

D. Mirzaeva, A. Prokhorova, B. Muinjanov, P. Deleyn (Tashkent, Uzbekistan)

12:00pm-1:30pm

Beliefs and knowledge on Parkinson’s disease (PD) among people with PD, the public and traditional healers in Western Cape, South Africa

J. Mokaya, J. Carr (Tygerberg, South Africa)

12:00pm-1:30pm

Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients

A. Romagnolo, M.G. Rizzone, F. Dematteis, M. Zibetti, A. Merola, L. Rizzi, E. Montanaro, C.A. Artusi, M. Lanotte, L. Lopiano (Turin, Italy)

12:00pm-1:30pm

Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)

12:00pm-1:30pm

Characterization of European longitudinal cohort studies in Parkinson’s disease – Report of the JPND working group BioLoC-PD

S. Lerche, I. Liepelt-Scarfone, G. Alves, P. Barone, S. Behnke, Y. Ben-Shlomo, H. Berendse, D. Burn, R. Dodel, D. Grosset, M. Hu, M. Kasten, R. Krüger, W. Maetzler, B. Mollenhauer, W. Oertel, U. Walter, K. Wirdefeldt, D. Berg (Tübingen, Germany)

12:00pm-1:30pm

Colonic α-synuclein: A potential diagnostic biomarker in Parkinson’s disease

C. Ruffmann, I. Poggiolini, N. Bengoa-Vergniory, F. Baig, M. Rolinski, J. Klein, M.T. Hu, R. Wade-Martins, J. Alegre-Abarrategui, L. Parkkinen (Oxford, United Kingdom)

12:00pm-1:30pm

Comparing quality of PD care in a comprehensive clinic to specialist care

S.A. Factor, L.P. Prizer, F.C. Goldstein, L.M. Trotti, A. Hermida, C. Vaughan (Atlanta, GA, USA)

12:00pm-1:30pm

Conjugal Parkinson´s disease – Real or chance?

B. Balint, R. Erro, F. Brugger, A. Batla, E. Antelmi, C. Ganos, K.P. Bhatia (London, United Kingdom)

12:00pm-1:30pm

Coupling between visual information and body sway in people with Parkinson’s disease

C.F. Cruz, L.A.O.A. Nóbrega, E. Okamoto, M.E.P. Piemonte, J.A. Barela (São Paulo, Brazil)

12:00pm-1:30pm

Creutzfeldt-Jakob disease presenting predominantly with movement disorder: A case report

A.A. Sann, M.M. Zaw, T.L. Choie (Yangon, Myanmar)

12:00pm-1:30pm

CSF level of chromogranin A in amyotrophic lateral sclerosis

M. Kaiserova, P. Otruba, K. Mensikova, Z. Grambalova, H. Prikrylova Vranova, J. Mares, D. Stejskal, P. Kanovsky (Olomouc, Czech Republic)

12:00pm-1:30pm

Deep brain stimulation of the locomotor mesencephalic region in rats with lesioned sensorimotor cortex: A model of functional motor recovery after stroke

F. Fluri, M.K. Schuhmann, C. Kleinschnitz, J. Volkmann (Würzburg, Germany)

12:00pm-1:30pm

Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model

P.C. Bhatt, V. Kumar (New Delhi, India)

12:00pm-1:30pm

Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)

12:00pm-1:30pm

Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease

S.H. Guptha (Peterborough, United Kingdom)

12:00pm-1:30pm

ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis

S. Mariani, P. Congiu, G. Milioli, G. Gioi, G. Borghero, F. Marrosu, R.J. Thomas, A.L. Goldberger, M. Puligheddu (Boston, MA, USA)

12:00pm-1:30pm

EEG Spectral power changes prior to non-epileptic seizures: A pilot study

A.M. Meppelink, I. Parees, M. Beudel, S. Little, M. Edwards (Groningen, Netherlands)

12:00pm-1:30pm

Effect of dopamine and L-3,4 – dihydroxyphenylalanine in treatment of experimental parkinsonism

M.U. Kulmanova (Tashkent, Uzbekistan)

12:00pm-1:30pm

Effect of nelotanserin on objective sleep parameters in a phase 2 study in patients with insomnia

W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, M. Sanchez, W. Shanahan (New York, NY, USA)

12:00pm-1:30pm

Effectiveness of Lee Silverman voice treatment big on improving gait and quality of life in Parkinson’s disease patients after STN-DBS

V.V.P. Kagita, N.N. Mohd, A.K. Puligopu, R.M. Kandadai, M.A. Kanikannan, S. Jabeen, R. Borgohain (Hyderabad, India)

12:00pm-1:30pm

Effects of movement rate and amplitude on repetitive finger motion in people with Parkinson’s disease and freezing of gait

M.P. Pereira, S. Vercruysse, E. Heremans, A. Nieuwboer (Leuven, Belgium)

12:00pm-1:30pm

European physiotherapy guideline for Parkinson’s disease: Information for neurologists

D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus (Nijmegen, Netherlands)

12:00pm-1:30pm

Evaluation of respiratory and depression levels of patients with Parkinson’s disease

E.E. Okuyucu, O. Canbay, E. Dogru, I. Huzmeli, N. Katayifci, F. Duman, N.C. Korkmaz, B. Yucekaya, E. Seker (Hatay, Turkey)

12:00pm-1:30pm

Examining the clinical profile of nelotanserin, a novel agent in development for Lewy body dementia

W. Wen, K. Kishnani, S. Ramaswamy, S. Piscitelli (New York, NY, USA)

12:00pm-1:30pm

Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up

M.T. Montojo, Y. Macias, M. ÁLvarez, C. Martín, L. Borrega, L. Vela (Alcorcón, Spain)

12:00pm-1:30pm

Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies

M. Takahashi, T. Uchihara, M. Yoshida, K. Wakabayashi, A. Kakita, H. Takahashi, S. Toru, T. Kobayashi, S. Orimo (Tokyo, Japan)

12:00pm-1:30pm

Fall status and stepping response: Individuals with PD are differently influenced by side-affected

B.N. Intzandt, E. Beck, M.P. Pereira, Q.J. Almeida (Waterloo, ON, Canada)

12:00pm-1:30pm

Finding an optimal lead trajectory for a better stimulated volume in movement disorder therapy

J. Perez, L. Cif, V. Gonzalez, E. Sanrey, F. Cyprien, P. Coubes (Montpellier, France)

12:00pm-1:30pm

Frequency of falls in nursing homes for neurodegenerative diseases

C. Godinho, J.M. Domingos, A.S. Pereira, M. Duarte, J.J. Ferreira (Lisboa, Portugal)

12:00pm-1:30pm

Gait and anthropometric characteristics of patients with Parkinson’s disease seen in a Nigerian tertiary hospital

A.O. Ogundele, M.O. Olaogun, M.A. Komolafe (Ile-Ife, Nigeria)

12:00pm-1:30pm

Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease

G. Costa, M.J. Sisalli, L. Contu, A. Scorziello, M. Morelli (Cagliari, Italy)

12:00pm-1:30pm

Glial cells and iron accumulation in the brain of the Zitter rat

T. Kadowaki, H. Lassmann, S. Ueda, C. Schuh, K. Hirata (Mibu, Japan)

12:00pm-1:30pm

Has iCare PD started in Singapore?

S.H.X. Liew, C. Cyq, N. Jcf, K. Sym, R.C.L. Ong (Singapore, Singapore)

12:00pm-1:30pm

Home care program for patients with Parkinson’s disease – A Singapore experience

H.L. Ng, W. Li, S. Abdul Karim, K.Y. Tay, W.L. Au, L.C.S. Tan (Singapore, Singapore)

12:00pm-1:30pm

How accurate is the prediction of driving ability in a Parkinson’s clinic setting?

C. Thomas, R. Amin, B. Mohamed (Cardiff, United Kingdom)

12:00pm-1:30pm

Improving the experience of diagnosis in Parkinson’s disease

C. Carroll, B. Blight, V. Evans, N. Hawkes, J. Davis (Plymouth, United Kingdom)

12:00pm-1:30pm

Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study

S. Aithal, C. Thomas, S. Raha, H. Shukla, L. Ebenezer, R. Sequeria, B. Mohamed (Caerphilly, United Kingdom)

12:00pm-1:30pm

Interdisciplinary allied health care in a southern Brazil service

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)

12:00pm-1:30pm

Is physiotherapy an effective for treatment of Parkinson’s disease?!

R. Agzamov, S. Tursunov, G. Rakhimbaeva, F. Yunusov, D. Lutfullaeva, J. Olimov, A. Kalendarev, K. Abdukhalimova, R. Mirzaev (Tashkent, Uzbekistan)

12:00pm-1:30pm

Long-latency somatosensory evoked potentials of the subthalamic nucleus

C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

12:00pm-1:30pm

Loss of heart rate variability in ALS: Time and frequency domain assessment

P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

12:00pm-1:30pm

Nursing diagnoses and interventions in rehabilitation related to antiParkinsonian pharmacotherapy

M.H.S. Tosin, B.G.R.B. Oliveira, T.R. Garcia (Rio de Janeiro, Brazil)

12:00pm-1:30pm

Ocular flutter in alcohol withdrawal syndrome

K.P. Frei, M. Dastjerdi, F.B. Pedouim, L.H. Sovory, K. Dashtipour (Loma Linda, CA, USA)

12:00pm-1:30pm

Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy

L.E. Katus, S.J. Frucht (New York, NY, USA)

12:00pm-1:30pm

Parkinson’s disease (PD) quality improvement measures (QIM) and outcomes study

J. Martello, L. Shulman, M. Armstrong, S. Reich (Baltimore, MD, USA)

12:00pm-1:30pm

Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA

B. Elibol, H. Onder, G.Y. Cakmakli, E.S. Topcuoglu (Ankara, Turkey)

12:00pm-1:30pm

Participant feedback in the PREDICT-PD study

C.W. Osborne, J. Bestwick, G. Giovannoni, A.J. Lees, A. Schrag, A. Noyce (London, United Kingdom)

12:00pm-1:30pm

Physical therapy, a third wheel in the management of Parkinson’s disease

M.V. Alvarez, M. Rodriguez (San Antonio, TX, USA)

12:00pm-1:30pm

Physiological and biomechanical responses of people with Parkinson’s during Zumba Gold®: Effects of dance styles and number of sessions

A. Delextrat, J. Bateman, P. Esser, N. Targen, H. Dawes, M.A. Delextrat (Oxford, United Kingdom)

12:00pm-1:30pm

Physiotherapy can reduce the decline in functioning according to ICF framework in patients in early stage of Parkinson’s disease evolution

E.T.N. Guelfi, E. Okamoto, F.B. Tarallo, J.C. Elmauer, R.R. Fermino, V.F. Giangiardi, P. Yuki, E.P. Piemonte (São Paulo, Brazil)

12:00pm-1:30pm

Predicting risk of sarcopenia in people with Parkinson’s disease

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel (Curitiba, Brazil)

12:00pm-1:30pm

Predictive validity of statistical models of Parkinson’s disease progression

A. Mendes, A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Bastos-Lima, S. Cavaco (Porto, Portugal)

12:00pm-1:30pm

Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism

G. Calandra-Buonaura, L. Sambati, I. Gessaroli, A. Turrini, R. Terlizzi, G. Giannini, P. Guaraldi, P. Cortelli (Bologna, Italy)

12:00pm-1:30pm

Profile of urgent care visits in movement disorders

J.T. Lazarus, V.D. Sharma, L. Scorr, S. Factor (Atlanta, GA, USA)

12:00pm-1:30pm

Progressive encephalomyelitis with rigidity and myoclonus (PERM) in an intellectually disabled patient initially misdiagnosed as neuroleptic malignant syndrome (NMS)

Z. Xu, K. Prasad, T. Yeo (Singapore, Singapore)

12:00pm-1:30pm

Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates

B.D. Wissel, A.K. Dwivedi, T.E. Gaston, F.J. Rodriguez-Porcel, D. Al Jaafari, J.L. Hopp, A. Krumholz, Y. Wang, S.M.A. van der Salm, D.M. Andrade, F. Borlot, B.D. Moseley, J.L. Cavitt, S. Williams, J. Stone, W.C. LaFrance Jr, J.P. Szaflarski, A.J. Espay (Cincinnati, OH, USA)

12:00pm-1:30pm

Relationship between balance, trunk impairment and hand function in Parkinson’s disease

B. Donmez Colakoglu, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)

12:00pm-1:30pm

Relationship of muscular strength with cardiovascular function in Parkinson’s disease

M.A. Alomari, H. Khalil, O.F. Khabour, E. Dersieh, J.A. Bajwa (Irbid, Jordan)

12:00pm-1:30pm

Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease

T.E. Apoznanski, S. Yao, M.K. Jung, J. DiFrancisco-Donoghue (Old Westbury, NY, USA)

12:00pm-1:30pm

Risk factors associated with postural changes in Parkinson’s disease

A. Khlebtovsky, O. Keret, Y. Rodity, G. Tsvetov, I. Slutzcki-Shraga, F. Benninger, R. Djaldetti (Petach Tikva, Israel)

12:00pm-1:30pm

Role of the nurse coordinator within a unit for treatment of neuro-surgical behaviours and abnormal movements

E. Borgeais, C. Fournera, I. Creff, P. Coubes (Montpellier, France)

12:00pm-1:30pm

Safety of nelotanserin in a randomized placebo-controlled phase 2 study

W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, S. Piscitelli, M. Sanchez, W. Shanahan (New York, NY, USA)

12:00pm-1:30pm

Sarcopenia and dynapenia in patients with parkinsonism

E. Cassani, E. Cereda, G. Pinelli, L. Iorio, A. Valentino, C. Pusani, V. Ferri, C. Bolliri, M. Pasqua, G. Frazzitta, M. Barichella, G. Pezzoli (Milano, Italy)

12:00pm-1:30pm

Self-perception of vocal handicap in Parkinson’s disease

A.K. Silbergleit, J. Wall, L. Schultz, J. Peacock, P.A. LeWitt (West Bloomfield, MI, USA)

12:00pm-1:30pm

Stiff person syndrome

P. Dosekova, G. Krastev, J. Haring, R. Lackovic (Trnava, Slovakia (Slovak Republic))

12:00pm-1:30pm

Stiff person syndrome: Case series

E. Sasse, G. Amorelli, M. Spitz, C.S.B. Germano, L.F. Vasconcellos (Rio De Janeiro, Brazil)

12:00pm-1:30pm

STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation

K.D. Sethi, A. Verma, C.A. Rosen, C.H. Adler, C.J. Bassich, T.L. Carroll, M.D. Stacy (Raleigh, NC, USA)

12:00pm-1:30pm

Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases

A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv (Uzhhorod, Ukraine)

12:00pm-1:30pm

Systems biological approach to Parkinson’s disease- Uncovering effects of PD on the synapse

K.F. Heil, O. Sorokina, J.D. Armstrong, J. Hellgren Kotaleski (Edinburgh, United Kingdom)

12:00pm-1:30pm

Testing for the “whack-a-mole” sign in the movement disorders clinic

J.E. Park, C. Maurer, M. Villegas, M. Hallett (Bethesda, MD, USA)

12:00pm-1:30pm

The communicative effectiveness survey-revised (CESR): An objective measure of communicative participation for people with Parkinson’s disease

N.J. Donovan (Baton Rouge, LA, USA)

12:00pm-1:30pm

The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2

F.S. Akhmedova, M.K.U. Tukhtamishev (Tashkent, Uzbekistan)

12:00pm-1:30pm

The effect of daytime working for development of sleep apnea in office workers

D.M. Sultonov, U.N. Vokhidov (Tashkent, Uzbekistan)

12:00pm-1:30pm

The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)

12:00pm-1:30pm

The role of acoustic salience in acoustic cueing and sound-based motor rehabilitation

B.G. Schultz, S.A. Kotz (Maastricht, Netherlands)

12:00pm-1:30pm

The role of active rehabilitation measures, for maintaining the quality of life of patients after stroke with movement disorders in the general practice conditions

G. Sadullaeva (Tashkent, Uzbekistan)

12:00pm-1:30pm

The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)

12:00pm-1:30pm

The serum response factor SRF protect dopamine (DA) neurons in Parkinson’s disease partially by mediate autophagy through a beclin 1-dependent pathway

X. Cheng (Suzhou, People's Republic of China)

12:00pm-1:30pm

Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II

R. López-Castellanos, R. López-Contreras (San Salvador, El Salvador)

12:00pm-1:30pm

TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells

X. Cheng, M. Wang (Suzhou, People's Republic of China)